BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37551460)

  • 1. [Analysis on Cellular Immune Function Recovery after HLA Mismatched Allogeneic Hematopoietic Stem Cell Micro-Transp- lantation in Elderly AML Patients].
    Jiang S; Liu RY; Liu TQ; Wang Y; Yu CL; Qiao JH; Cai B; Lei YY; Ai HS; Guo M; Hu KX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Auguest; 31(4):945-953. PubMed ID: 37551460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-mismatched micro-transplantation as post-remission treatment compared to autologous hematopoietic stem cell transplantation or consolidation with single agent cytarabine for favorable-or intermediate-risk acute myeloid leukemia.
    Tao S; Zhou D; Song L; Deng Y; Chen Y; Ding B; He Z; Wang C; Yu L
    Hematology; 2023 Dec; 28(1):2231733. PubMed ID: 37408450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoietic stem cell microtransplantation in patients aged over 70 with acute myeloid leukemia: a multicenter study.
    Hu KX; Guo M; Yu CL; Qiao JH; Sun QY; Cai B; Zhan XR; Shen XL; Fan CB; Ai HS; Wang Y
    Am J Cancer Res; 2023; 13(4):1509-1521. PubMed ID: 37168346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes of lymphocyte subsets in acute leukemia patients after HLA-mismatched nonmyeloablative hematopoietic stem cell transplantation].
    Hu KX; Guo M; Yu CL; Wang DH; Sun QY; Qiao JH; Liu GX; Liu TQ; Ai HS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1527-31. PubMed ID: 20030940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical Efficacy and Survival Analysis of Adult Patients with Acute Myeloid Leukemia after Microtransplantation].
    Huang YJ; Zhang JH; Dong CX; Kang JM; Hou YF; Zhang YF; Qi K; Yang LH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1361-1368. PubMed ID: 36208236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical Safety of NK Cell in the Prevention of Leukemia Relapse Post-transplantation and in Treatment of the Elderly Leukemia Patients].
    Liu J; Zheng XL; Xue M; Zhu L; Ding L; Han DM; Yan HM; Li S; Ma JD; Tan XT; Zhou JX; Guo ZK; Wang HX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Aug; 30(4):1267-1271. PubMed ID: 35981396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The Relationship between Occurrence of aGVHD in Patients with Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation and Immune Cell Components in Graft].
    Liu S; Zhou Z; Zhai WJ; Song XN; Li Q; Jiang EL; Feng SZ; Sun JL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Apr; 31(2):539-545. PubMed ID: 37096531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased TOX expression concurrent with PD-1, Tim-3, and CD244 expression in T cells from patients with acute myeloid leukemia.
    Huang S; Liang C; Zhao Y; Deng T; Tan J; Zha X; Li Y; Chen S
    Cytometry B Clin Cytom; 2022 Mar; 102(2):143-152. PubMed ID: 34913594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Study of Human Leukocyte Antigen Mismatched Cellular Therapy (Stem Cell Microtransplantation) in High-Risk Myelodysplastic Syndrome or Transformed Acute Myelogenous Leukemia.
    Hu KX; Sun QY; Guo M; Qiao JX; Yu CL; Qiao JH; Dong Z; Sun WJ; Zuo HL; Huang YJ; Cai B; Ai HS
    Stem Cells Transl Med; 2016 Apr; 5(4):524-9. PubMed ID: 26838271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different immune reconstitution in multiple myeloma, chronic myeloid leukemia and acute myeloid leukemia patients after allogeneic transplantation of peripheral blood stem cells.
    Rondelli D; Re F; Bandini G; Raspadori D; Arpinati M; Senese B; Stanzani M; Bonifazi F; Falcioni S; Chirumbolo G; Tura S
    Bone Marrow Transplant; 2000 Dec; 26(12):1325-31. PubMed ID: 11223973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes of T Cell Subsets and Their Relationship with Clinical Features and Prognosis in Patients with Acute Leukemia].
    Zheng RH; Yu BD; Zheng LX; Wang CY; Qin PF; Luo XD; Lin JR; Tan H; Xu J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Oct; 26(5):1309-1316. PubMed ID: 30295243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-transplant immune reconstitution after unrelated allogeneic stem cell transplant in patients with acute myeloid leukemia.
    Klyuchnikov E; Asenova S; Kern W; Kilinc G; Ayuk F; Wiedemann B; Lioznov M; Freiberger P; Zalyalov Y; Zander AR; Kröger N; Bacher U
    Leuk Lymphoma; 2010 Aug; 51(8):1450-63. PubMed ID: 20557144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectral flow cytometry cluster analysis of therapeutic donor lymphocyte infusions identifies T cell subsets associated with outcome in patients with AML relapse.
    Odak I; Sikora R; Riemann L; Bayir LM; Beck M; Drenker M; Xiao Y; Schneider J; Dammann E; Stadler M; Eder M; Ganser A; Förster R; Koenecke C; Schultze-Florey CR
    Front Immunol; 2022; 13():999163. PubMed ID: 36275657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection and Analysis of T Lymphocyte Subsets and B Lymphocytes in Patients with Acute Leukemia].
    Cheng J; Ma HZ; Zhang H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Apr; 27(2):327-330. PubMed ID: 30998133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune reconstitution after autologous hematopoietic stem cell transplantation in relation to underlying disease, type of high-dose therapy and infectious complications.
    Steingrimsdottir H; Gruber A; Björkholm M; Svensson A; Hansson M
    Haematologica; 2000 Aug; 85(8):832-8. PubMed ID: 10942930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced Immune Reconstitution of γδ T Cells after Allogeneic Stem Cell Transplantation Overcomes the Negative Impact of Pretransplantation Minimal Residual Disease-Positive Status in Patients with Acute Myelogenous Leukemia.
    Klyuchnikov E; Badbaran A; Massoud R; Fritsche-Friedland U; Janson D; Ayuk F; Wolschke C; Bacher U; Kröger N
    Transplant Cell Ther; 2021 Oct; 27(10):841-850. PubMed ID: 34118468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Characteristics of T-cell immunity in patients with acute leukemia].
    Parovichnikova EN; Gal'tseva IV; Vorob'ev IA; Savchenko VG
    Ter Arkh; 2006; 78(7):18-25. PubMed ID: 16944746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haploidentical Natural Killer Cells Infused before Allogeneic Stem Cell Transplantation for Myeloid Malignancies: A Phase I Trial.
    Lee DA; Denman CJ; Rondon G; Woodworth G; Chen J; Fisher T; Kaur I; Fernandez-Vina M; Cao K; Ciurea S; Shpall EJ; Champlin RE
    Biol Blood Marrow Transplant; 2016 Jul; 22(7):1290-1298. PubMed ID: 27090958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unrelated cord blood transplantation vs. HLA-matched sibling transplantation for adults with B-cell acute lymphoblastic leukemia in complete remission: superior OS for patients with long-term survival.
    Sun G; Tang B; Song K; Wu Y; Tu M; Wan X; Yao W; Geng L; Qiang P; Zhu X
    Stem Cell Res Ther; 2022 Oct; 13(1):500. PubMed ID: 36210439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical significance of detecting peripheral T cell subsets in children with leukemia].
    Li XM; Wang HX; Xiong HX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Dec; 22(6):1521-4. PubMed ID: 25543467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.